GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV ... undetectable after stopping all treatment. In B-Clear, patients with low baseline ...

In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

Besifovir dipivoxil maleate (BSV) is another drug that has been shown to have an antiviral ... These findings offer new hope for patients undergoing long-term antiviral treatment for hepatitis B. More ...

Lamivudine oral tablet is a generic prescription drug used to treat HIV alongside other antiretroviral drugs, and to treat long-term hepatitis B. It’s usually taken once or twice per day.

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Non-cirrhotic patients on a treatment regimen of ... commercialisation of innovative drugs against hepatitis C virus (HCV), AIDS (HIV) and the hepatitis B virus (HBV). The company is currently ...

Hepatitis can damage your liver for years without symptoms. Learn how these viruses spread—and what truly protects your liver ...

Uncover what drives alcoholic hepatitis, how it’s detected, and why stopping alcohol is vital for better health and recovery.

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.